Growth in the US market for gynecological devices will be driven primarily by growing adoption of hormonal IUDs, hysterscopic morcellators, and ARC devices. The market will also be fueled by the growing shift toward office-based procedures due to growing awareness of less invasive treatment options for various gynecological conditions and improving reimbursement for this site of service. In contrast, the market will be limited by a range of safety issues that have led to recalls of major products in the market. Additionally, the COVID-19 pandemic will limit growth over the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for gynecological devices in the US across a 10-year period.

The COVID-19 pandemic will negatively impact the US gynecological device market.

Which types of procedures and device segments will be most impacted?

At what pace are gynecological device markets expected to recover?

While most segments of the market will grow throughout the forecast, some segments will exhibit particularly strong growth.

Which segments contribute the most to the overall growth of the market?

How will growing adoption of hysteroscopic morcellators affect the hysteroscopic resection device market?

There continues to be an increasing preference for in-office procedures across multiple device segments.

What factors are driving the increase in office-based procedure volumes?

How will this influence the sale of devices in the impacted markets?

A number of successful products from major competitors have been removed from the market in recent years.

Which products have been withdrawn from the market?

How will this impact the markets in which they previously competed?

How will this impact market shares and sales strategies of other competitors in those markets?

Table of contents

  • Gynecological Devices - Market Insights - United States

Author(s): Benny Jacob, MS

Benny Jacob is an analyst on the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at DRG (Part of Clarivate), specializing in the ENT Devices market. Benny has a background that covers Data Science, Systems Neuroscience and Bioinformatics. Benny has a Masters' Degree in Computational Biology from Carnegie Mellon University, Pittsburgh and a Bacherlor's Degree in Biotechnology from Manipal Institute of Technology, Manipal (India).